PreserveIQ: recover value after a negative HTA decision

A negative decision creates immediate pressure to discount.

Price is only one lever, and rarely the one that decides the outcome.

Conceding early costs twice: value is given up, and access rarely improves.

The barrier usually sits elsewhere, in evidence, positioning or budget impact.

The managed recovery path

How does PreserveIQ work?

Four questions, answered in sequence. Each one narrows the response before any concession is made, so that evidence and access terms are used before price.

Diagnose

What blocked reimbursement, and what remains winnable?

Read the decision as the payer wrote it; isolate the objections and the remaining negotiating strength.

Test

Would a price concession materially change the outcome?

Separate decisions where price can buy access from those where it cannot.

Prioritize

Which fixes matter, and which are feasible?

Rank evidence, access terms and price by impact and by feasibility.

Sequence

What is the negotiation plan?

Evidence first. Access terms next. Price last, and only where it solves the problem.

What does PreserveIQ deliver?

✓Read of the decision: what blocks access, what leverage remains.
✓Ranked gaps: what drove the refusal, by impact and by feasibility.
✓Negotiation posture and plan: evidence, access terms, price, in that order.

When does it apply?

→Negative, restricted or delayed reimbursement decision
→Resubmission, appeal or renegotiation in preparation
→Discount considered as the first response

The four recovery levers

Which levers remain after a refusal?

Evidence

Close the gap the payer named: comparator, endpoint or certainty.

Positioning

Start where the case is strongest, then widen the population.

Access terms

Share the risk: managed entry, outcomes or volume agreements.

Price

Used last, and only where the assessment shows it changes the decision.

Frequently asked

Questions about recovery after a negative decision

What is the first step after a negative HTA decision?

Read the decision as the payer wrote it. The first step is to isolate the stated objections, separate them from the negotiating position, and establish what remains winnable. Discounting before that read is complete concedes value against a barrier that may not be about price at all.

Does a price discount usually reverse a negative recommendation?

Rarely on its own. Most negative decisions cite evidence, comparator or budget impact issues that a lower price does not repair. A discount changes the outcome only where the assessment shows price was the deciding factor. PreserveIQ tests that question before any concession is made.

What is the difference between a resubmission, an appeal and a renegotiation?

A resubmission presents a revised evidence package to the same agency. An appeal challenges the process or the reading of the evidence within a set window. A renegotiation reopens access terms and price with the payer without a new assessment. Each route suits a different blocker.

How long does a recovery process take?

The diagnostic read of a decision takes weeks, not months, because it works from the published assessment and the sponsor's own dossier. The full recovery timeline then depends on the route chosen: appeals run on fixed agency windows, resubmissions follow the evidence, renegotiations follow the payer calendar.

Which markets does PreserveIQ cover?

PreserveIQ is grounded in recovery cases across the US, Canada, the UK and Germany, and the method applies to any market with a formal HTA or payer decision. The four levers (evidence, positioning, access terms, price) are read against the specific agency's criteria and process.

Turn a negative HTA decision into a managed recovery.